BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

SMSbiotech Launches First-in-Human Trial of Small Mobile Stem Cells for COPD in Australia

SMSbiotech, a San Diego–based leader in regenerative medicine, announced the initiation of its first-in-human Phase 1 clinical trial for C...

August 22, 2025 | News

Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025

The first eight months of 2025 have been transformative for biosupplier technologies worldwide. From innovative lab reagents and biomaterials to ad...

August 22, 2025 | Analysis

Avive Health and Emyria Partner to Open Queensland’s First Empax Clinic for PTSD and Depression

Avive Health ("Avive"), an Australian-owned private mental health provider, has announced a major national partnership with Emyria Limited (ASX: EMD), mark...

August 14, 2025 | News

PolyActiva Launches U.S. Trial of Glaucoma Implant Following Australia Success

PA5108, a new chemical entity, is an investigational, biodegradable ocular micro implant, designed to deliver sustained intraocular pressure control for ...

August 08, 2025 | News

Eflornithine Added to Australia’s PBS for Children with High-Risk Neuroblastoma

Eflornithine is now reimbursed by the government under Australia's Pharmaceutical Benefits Scheme (PBS). The Pharmaceutical Benefits Advisory C...

August 04, 2025 | News

VB Spine Expands Globally with Acquisition of Stryker’s Spinal Implants Business in Australia and New Zealand

Stryker’s spinal implants business in Australia and New Zealand fully transitions to VB Spine and LifeHealthcare continues as exclusive distributor...

August 01, 2025 | News

Medidata Expands Partnership with NHMRC Clinical Trials Centre to Accelerate Innovation in Australian Clinical Research

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and rai...

July 10, 2025 | News

Clasado Biosciences Gains TGA Approval for Bimuno® GOS in Australia’s Therapeutic Supplement Market

Clasado Biosciences has announced that its prebiotic ingredient Bimuno® GOS is now available for use in Therapeutic Goods Administration (TGA)-listed p...

July 07, 2025 | News

Akeso Doses First Patient in Phase Ia Trial of AK146D1, the World’s First Bispecific ADC Targeting Trop2 and Nectin4

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...

July 04, 2025 | News

Infosys and Mental Health Foundation Australia Launch ‘Supportive Mind’ App to Promote Mental Well-Being Across ANZ

Infosys, a global leader in next-generation digital services and consulting, today announced a strategic collaboration with Mental Health Founda...

June 27, 2025 | News

QBiotics Reports 80% Response Rate in Phase IIa Soft Tissue Sarcoma Trial for Tigilanol Tiglate

Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate in 11 (10 evaluable) p...

June 26, 2025 | Report

Clarity and SpectronRx Sign US Manufacturing Deal for 64Cu-SAR-bisPSMA to Expand Access for Australia and the US

Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for 64Cu-SAR-bisPSMA. SpectronRx's facility in Indiana will...

June 18, 2025 | News

Specialised Therapeutics Expands Incyte Partnership to Launch Axatilimab and Retifanlimab in Asia-Pacific

Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agree...

June 13, 2025 | News

Cytiva’s $1.6B Expansion Across 3 Continents to Boost Bioprocessing Supply

Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and ...

June 12, 2025 | News

Stay Connected